PATENT CLAIM ANALYSIS

Application Number: 15962200
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["530", "317000"]

Abstract:
The subject invention provides compositions and methods for alleviating pain. Specifically, the subject invention provides pharmaceutical formulations of peptides, and/or their salts, having advantageous μ-opioid receptor binding activity.

Claim (Index 14):
The method, according to  claim 11 , wherein the peptide is selected from SEQ ID NOs: 1 to 26.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.22222
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13477423', '11278014', '11007772', '11267257', '10758572']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6997348812757559
- 35 USC 102 Novelty (BERT): 0.5093186812637128
- Combined Prediction Score: 0.6806932612745517
- Mean Citation Score: 258.154796
- Max Citation Score: 269.96765
- Similarity Product: 183.79687814556647

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test